| Serial Number | 98113085 |
| Word Mark | CHROMA |
| Filing Date | Wednesday, August 2, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 12, 2024 |
| Registration Number | 7562466 |
| Registration Date | Tuesday, November 12, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 27, 2024 |
| Goods and Services | Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity |
| Goods and Services | Research, development, and design of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine design, discovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligence, namely, data automation and collection service using proprietary software to evaluate, analyze and collect biological data; computer assisted molecule design involving the use of artificial intelligence technology, namely, product design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug development, namely, scientific research in the field of pharmaceuticals; providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 31, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | Wednesday, November 15, 2023 |
| First Use In Commerce Date | Wednesday, November 15, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 31, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, November 15, 2023 |
| First Use In Commerce Date | Wednesday, November 15, 2023 |
| Party Name | Generate Biomedicines, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
| Party Name | Generate Biomedicines, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Generate Biomedicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, December 12, 2023 | USE AMENDMENT FILED |
| Saturday, August 5, 2023 | NEW APPLICATION ENTERED |
| Thursday, August 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 11, 2023 | TEAS AMENDMENT OF USE RECEIVED |
| Tuesday, December 12, 2023 | AMENDMENT TO USE PROCESSING COMPLETE |
| Wednesday, April 3, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 10, 2024 | USE AMENDMENT ACCEPTED |
| Wednesday, April 10, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 10, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 11, 2024 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Wednesday, July 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 27, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 27, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 12, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Monday, February 3, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 3, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, February 3, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, November 12, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Monday, February 3, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 3, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 3, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 3, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 3, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |